Seoul, South Korea

Ok-Jin Park

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Nibec Co., Ltd., Seoul National University, Snu Rdb Foundation. Active years: 2018-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ok-Jin Park. Retrieved from https://idiyas.com/inventor/ok-jin-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovations of Ok-Jin Park: Pioneering Advances in Biomedical Science**

Introduction

Ok-Jin Park, an accomplished inventor based in Seoul, South Korea, has made significant contributions to the field of biomedical science. With a total of two patents to his name, his work focuses on crucial areas such as biofilm inhibition and bone regeneration. His inventions have the potential to improve treatment options in dentistry and orthopedic medicine.

Latest Patents

1. **Peptide for Inhibiting Biofilms**

This innovative patent pertains to a composition designed to inhibit biofilms, featuring a peptide derived from human β-defensin-3 as its active ingredient. This particular peptide has shown efficacy in inhibiting bacterial biofilms, demonstrating exceptional results even when used independently. Moreover, when combined with conventional dental therapeutic agents, it not only enhances the inhibitory effect on biofilms but also prevents tooth discoloration, a common side effect associated with existing treatments.

2. **Bone Loss Preventing and Bone Regeneration Promoting Pharmaceutical Composition**

In this patent, Ok-Jin Park presents a pharmaceutical composition that includes muramyl dipeptide or its analogs and derivatives. Unlike traditional agents that focus primarily on suppressing bone absorption, this composition serves a proactive role by promoting the differentiation of osteoblasts—cells responsible for bone formation. This innovation offers a unique therapeutic avenue for treating various conditions that require enhanced bone growth, highlighting Park's commitment to advancing patient care.

Career Highlights

Ok-Jin Park has been associated with prestigious institutions such as Seoul National University and Nibec Co., Ltd. His work in these organizations has fostered his development as an inventor in the biomedical field, allowing him to cultivate a rich understanding of the applications of his innovations.

Collaborations

Throughout his career, Ok-Jin Park has collaborated with notable professionals, including his colleagues Seung Hyun Han and Kee-Yeon Kum. These partnerships have likely played a pivotal role in the refinement and application of his inventions, showcasing the importance of teamwork and interdisciplinary approaches in research and development.

Conclusion

In conclusion, Ok-Jin Park is a distinguished inventor whose work is reshaping the landscape of biomedical innovations. His patents not only advance scientific understanding but also promise to enhance therapeutic options in dentistry and orthopedics. As the field continues to evolve, Park's contributions will undoubtedly remain influential in fostering healthier outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…